Llwytho...
Targeting B-cell maturation antigen in multiple myeloma
Novel effective immunotherapies are needed for patients with multiple myeloma (MM), since disease recurrence remains a major obstacle. B-cell maturation antigen (BCMA), a cell surface protein universally expressed on malignant plasma cells , has emerged as a very selective antigen to be targeted in...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Immunotherapy |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Future Medicine Ltd
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4976846/ https://ncbi.nlm.nih.gov/pubmed/26370838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.15.77 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|